The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(Cyclobutylamino)-9-propyl-8-phenyl-9H-purine ID: ALA4164048
PubChem CID: 11565780
Max Phase: Preclinical
Molecular Formula: C18H21N5
Molecular Weight: 307.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCn1c(-c2ccccc2)nc2c(NC3CCC3)ncnc21
Standard InChI: InChI=1S/C18H21N5/c1-2-11-23-17(13-7-4-3-5-8-13)22-15-16(19-12-20-18(15)23)21-14-9-6-10-14/h3-5,7-8,12,14H,2,6,9-11H2,1H3,(H,19,20,21)
Standard InChI Key: GYYOGZWIGPQOGZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
13.0076 -18.5725 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0065 -19.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7145 -19.8010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7127 -18.1636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4213 -18.5689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4216 -19.3921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2046 -19.6462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6883 -18.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2042 -18.3143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5022 -18.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9105 -19.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7269 -19.6877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1361 -18.9793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7228 -18.2694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9078 -18.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7103 -17.3464 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4573 -20.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0014 -16.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7875 -16.1487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9988 -16.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2126 -17.1512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2567 -20.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5094 -21.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
4 16 1 0
7 17 1 0
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 18 1 0
17 22 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 307.40Molecular Weight (Monoisotopic): 307.1797AlogP: 3.87#Rotatable Bonds: 5Polar Surface Area: 55.63Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.44CX LogP: 3.81CX LogD: 3.81Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: -1.24
References 1. Lambertucci C, Marucci G, Dal Ben D, Buccioni M, Spinaci A, Kachler S, Klotz KN, Volpini R.. (2018) New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases., 151 [PMID:29614417 ] [10.1016/j.ejmech.2018.03.067 ]